Eisai
Bookmark
ShareCopied to clipboardEisai is a company. It is a private company in Cambridge, the United States. It was founded in 1987 and it is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Key facts
- city: Cambridge
- country: United States
- employees: Try Pro to see estimate
- revenues: Try Pro to see estimate
- company type: private
- sector: Health Care
- industry: Pharmaceuticals
- foundation year: 1987
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about Eisai:
Dataset of stocks from Eisai:
Eisai is one of the companies in the United States, companies in Pharmaceuticals, companies in Health Care, companies in Cambridge and 3,456,808 companies in our database.
Talking Points
- A researchbased pharmaceutical company | Eisai US
- Eisai is a research-based human health care company that discovers, develops and markets phamaceutical products internationally. Learn more about Eisai today.
- Eisai Co., Ltd.｜A human health care company
- Welcome to the Eisai Official Corporate Website Eisai Co., Ltd. Page.
- Official account of Eisai Co., Ltd. At Eisai, human health care (hhc) is our goal. ヒューマン・ヘルスケア(hhc)のエーザイ株式会社の公式アカウントです。
- Breaking through in the therapeutic areas of oncology and neurology. | At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient ...
- Working towards a world without cancer | Eisai Inc.
- As a human health care company, we are committed to pursuing breakthroughs in Oncology until the world is cancer-free. Learn more about our mission to end cancer.
- Human. Health. Hope. | H3 Biomedicine is a privately held biopharmaceutical company focused on the discovery and early development of novel, targeted anti-cancer compounds for the unmet needs of genetically defined patient populations. H3 has leveraged its integrated expertise in genomics, tumor biology, bioinformatics and innovative synthetic ...
- Epochal Precision Anti-Cancer Therapeutics (EPAT) | Eisai Inc.
- EPAT is developing precision oncology therapies with the goal of improving results with fewer side effects. Discover the breakthrough therapies being developed.
- Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues ...